Earlier this month, BioNTech and Pfizer asked U.S. regulators to approve emergency use of their COVID-19 vaccine for adolescents aged 12 to 15.
Pfizer-BioNTech could test vaccine on kids as young as 6 months by September
Earlier this month, BioNTech and Pfizer asked U.S. regulators to approve emergency use of their COVID-19 vaccine for adolescents aged 12 to 15.